ESC 365 - Extended treatment of venous thromboembolism: for whom and for how long?

Open Access

Extended treatment of venous thromboembolism: for whom and for how long?

Session: Transforming patient care in venous thromboembolism – The role of non-vitamin K antagonist oral anticoagulants

Topic: Treatment

Speaker: Professor D. Jimenez (Madrid, ES)

Sponsored by Bristol-Myers Squibb and Pfizer Alliance

Event: ESC Congress 2018

Congress Presentation

About the speaker

Professor David Jimenez

Ramon and Cajal University Hospital, Madrid (Spain)

18 presentations

0 follower

4 more presentations in this session

Transforming patient care in venous thromboembolism – The role of NOACs: introduction.

Speaker: Professor S. Konstantinides (Mainz, DE)

Improving venous thromboembolism treatment outcomes with NOACs – Learnings from RCTs and clinical practice.

Speaker: Doctor A. Cohen (London, GB)

Evolving anticoagulation for venous thromboembolism: focus on patients with cancer.

Speaker: Professor G. Agnelli (Perugia, IT)

Transforming patient care in venous thromboembolism – lessons learned: Q&A.

Speaker: Professor S. Konstantinides (Mainz, DE)

Access the full session

Transforming patient care in venous thromboembolism – The role of non-vitamin K antagonist oral anticoagulants

Speakers: Professor D. Jimenez, Professor S. Konstantinides, Doctor A. Cohen, Professor G. Agnelli, Professor S. Konstantinides

About the event

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources